Remove 2010 Remove Prescription Remove Sales
article thumbnail

ELITE 2023 Sales MVP Laura Blair of ConnectiveRx

PM360

After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010. Laura is not shy about sharing her cancer experience. Laura has educated the new ConnectiveRx employees on the “real” patient journey.

Sales 94
article thumbnail

The future of pain medication: are cannabinoids the solution to the opioid epidemic?

Pharmaceutical Technology

In 2022, the FDA awarded VX-548 breakthrough therapy and fast-track designations for post-operative pain, and the drug is forecast to reach sales of $416m by 2029. Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010.

Medical 143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Navigating the Challenges of Biopharma Product Launches: A Blueprint for Success

PM360

The landscape is highly competitive with new prescription medications launching worldwide each year. According to a McKinsey report , a startling 40% of biopharma products fail to meet their sales forecasts within the initial two years, prompting a critical reassessment of strategies for product launches.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. Ex-Novartis sales representative Steven Camburn filed a whistleblower case that claimed Novartis had paid doctors up to $3,500 to participate in educational speaker programs to increase the promotion and prescription of Gilenya.

article thumbnail

The Witty Answer to GSK’s Future

Pharmaceutical Technology

Important elements within this expectation are the build up of strong contributions from Rotarix, Cervarix and Tykerb, while the outlook for GSK’s important asthma franchise becomes less clear beyond 2010. “Sales generated by new products are vital to the growth of the industry.”

article thumbnail

How HealthTrackRx Revolutionized PCR Testing by Delivering Next-Morning Results at Scale

Healthcare Success

On top of that, weve found that the best way to drive provider adoption is a mix of targeted digital marketing and in-person sales efforts. Our business has existed since around 2010. So many times, the prescription is not needed, and even when one is now written, it's just not going to work. or 48 continental states.

article thumbnail

Addressing Mental Health And Drug Addiction With Zack Cooper

Evolve Your Success

I have a big playlist of medical sales, medical information, news and innovation. While I was there, I met the hospice world, hospice sales and the ins and outs of hospice care. I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. This is a whole new thing for you?